Cinacalcet ( DrugBank: Cinacalcet )


1 disease
IDDisease name (Link within this page)Number of trials
238Vitamin D-resistant rickets3

238. Vitamin D-resistant rickets


Clinical trials : 29 Drugs : 25 - (DrugBank : 11) / Drug target genes : 4 - Drug target pathways : 20
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01748812
(ClinicalTrials.gov)
November 16, 201211/12/2012Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)Open-label Dose-titration Study of the Tolerability and Efficacy of Cinacalcet to Treat Fibroblast Growth Factor 23 (FGF23)-Mediated HypophosphatemiaOsteomalaciaDrug: OsteomalaciaNational Institute of Dental and Craniofacial Research (NIDCR)NULLTerminated18 Years70 YearsAll1Phase 1United States
2NCT00844740
(ClinicalTrials.gov)
February 200912/2/2009Calcimimetics in Hypophosphatemic RicketsEffect of Cinacalcet on the Long-Term Treatment of Familial Hypophosphatemic RicketsFamilial Hypophosphatemic RicketsDrug: CinacalcetChildren's Mercy Hospital Kansas CityNULLEnrolling by invitation5 Years21 YearsBoth10N/AUnited States
3NCT00195936
(ClinicalTrials.gov)
June 200513/9/2005Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic RicketsEffect of Calcimimetic (Cinacalcet) on Phosphate-Induced Hyperparathyroidism in Children With Hypophosphatemic RicketsHypophosphatemic Rickets, X-Linked DominantDrug: CinacalcetChildren's Mercy Hospital Kansas CityNULLCompleted5 YearsN/AAll8Phase 1United States